Track Gerresheimer AG — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Gerresheimer AG GXI.VI · Stock Open Gerresheimer AG in new tab

26.44 EUR
EPS
-9.27
Yield
0.15%
P/B
0.84
ROE
-24.41
Beta
0.47
Loading chart...
Key Metrics
EPS-9.27
Book Value31.30
Price to Book0.84
Debt/Equity207.98
% Insiders11.423%
Growth
Revenue Growth0.22%
Dividend
Dividend Yield0.15%
Annual dividends0.04 EUR
Ex-Div. DateJune 6, 2025
Payout5.88%
5y avg Yield1.27%

DCF Valuation

Tweak assumptions to recompute fair value for Gerresheimer AG (GXI.VI)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Gerresheimer AG Logo Gerresheimer AG Analysis (GXI.VI)

Germany Health Care Official Website Stock

Is Gerresheimer AG a good investment? Gerresheimer AG (GXI.VI) is currently trading at 26.44 EUR.

For income investors, Gerresheimer AG pays a dividend yield of 0.15%. With a payout ratio of 6%, the dividend appears sustainable.

Investor FAQ

Does Gerresheimer AG pay a dividend?

Yes, it pays an annual dividend of 0.04 EUR (0.15% yield).

What asset class is Gerresheimer AG?

Gerresheimer AG is classified as a Stock. You can compare it against 10 other assets in the "Related Symbols" list on this page.

Company Profile

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Exchange Ticker
PNK (United States) GRRMF
MUN (Germany) GXI.MU
FRA (Germany) GXI.F
VIE (Austria) GXI.VI
GER (Germany) GXI.DE
BER (Germany) GXI.BE
DUS (Germany) GXI.DU
HAN (Germany) GXI.HA
HAM (Germany) GXI.HM
STU (Germany) GXI.SG
Trades
Dividend Yield
0.15%
5y avg 1.27%
Annual Dividends
0.04EUR
Next Ex. Div Date
June 6, 2025
Payout Ratio
5.88%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2025
0.04 EUR
June 6, 2025 0.0400
2024
1.25 EUR
June 6, 2024 1.2500
2023
1.25 EUR
June 8, 2023 1.2500
2022
1.25 EUR
June 9, 2022 1.2500
2021
1.25 EUR
June 10, 2021 1.2500
2020
1.20 EUR
June 25, 2020 1.2000
2019
1.15 EUR
June 7, 2019 1.1500
2018
1.10 EUR
April 26, 2018 1.1000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion